Rankings
▼
Calendar
ZTS Q4 2024 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
Q4 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.3B
+4.7% YoY
Gross Profit
$1.6B
68.0% margin
Operating Income
$765M
33.0% margin
Net Income
$581M
25.1% margin
EPS (Diluted)
$1.29
QoQ Revenue Growth
-3.0%
Cash Flow
Operating Cash Flow
$905M
Free Cash Flow
$689M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$14.2B
Total Liabilities
$9.5B
Stockholders' Equity
$4.8B
Cash & Equivalents
$2.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.3B
$2.2B
+4.7%
Gross Profit
$1.6B
$1.4B
+8.8%
Operating Income
$765M
$709M
+7.9%
Net Income
$581M
$525M
+10.7%
Revenue Segments
Horses
$5.8B
89%
Cattle
$399M
6%
Swine
$128M
2%
Poultry
$117M
2%
Fish
$65M
1%
Geographic Segments
United States Segment
$1.3B
55%
International Segment
$1.0B
45%
← FY 2024
All Quarters
Q1 2025 →